Session information

[WFNMB]

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » Symposium

Symposium11

Radioiodine therapy for thyroid cancer : A current status report

Sun. Sep 11, 2022 9:15 AM - 10:45 AM Room3 (Kyoto International Conference Center 1F Annex2)

Chair：Emerita Barrenechea (Philippine Society of Nuclear Medicine, Philippine), Shingo Baba (Department of radiology, Kyushu University)

+Add all to schedule

[WSY11-1] Radioactive iodine therapy for differentiated thyroid carcinoma; indications and limitations

Yasuhiro Ito¹、Akira Miyauchi²、Takashi Akamizu³ (1.Department of Clinical Trial, Kuma Hospital, Kobe, Japan、2.Department of Surgery, Kuma Hospital、3.Department of Internal Medicine, Kuma Hospital)

[WSY11-2] Recent Updates of Molecular Targeted Treatment for Advanced Thyroid Cancer

Naomi Kiyota (Cancer Center, Kobe University Hospital, Kobe, Japan)

[WSY11-3] Radioiodine therapy of differentiated thyroid cancer: Current status and future perspective

Jaetae Lee (Kyungpook National University, Korea)

▲